News NATCO Pharma Limited

Equities

NATCOPHARM

INE987B01026

Delayed NSE India S.E. Other stock markets 06:19:12 2024-04-25 am EDT			5-day change	1st Jan Change
1,021 ^INR	+2.26%		+2.52%	+25.86%

Apr. 09	Natco Pharma Gets US FDA Warning Letter after Inspection of Kothur, India Unit	MT
Mar. 27	NATCO Pharma Limited Announces Board Appointments	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Natco Pharma Gets US FDA Warning Letter after Inspection of Kothur, India Unit	Apr. 09	MT
NATCO Pharma Limited Announces Board Appointments	Mar. 27	CI
INDIA STOCKS-Indian shares erase early gains, weighed down by IT stocks	Feb. 18	RE
NATCO Pharma Limited Revises Earnings Guidance for the Fiscal Year 2024	Feb. 15	CI
Transcript : NATCO Pharma Limited, Q3 2024 Earnings Call, Feb 15, 2024	Feb. 15
Corporate Action-Board Approves Third Interim Dividend for the Financial Year 2023-24, Payable on 4 March 2024	Feb. 14	CI
NATCO Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 14	CI
Cellogen Therapeutics announced that it has received $2 million in funding from NATCO Pharma Limited	Jan. 16	CI
Floods Disrupt Operations of Natco Pharma's Plant in Tamil Nadu, India	Dec. 07	MT
Transcript : NATCO Pharma Limited, Q2 2024 Earnings Call, Nov 15, 2023	Nov. 15
Natco Pharma's Consolidated Profit Soars in Fiscal Q2, Declares Second Interim Dividend	Nov. 14	MT
NATCO Pharma Limited Declares Second Interim Dividend for the Financial Year 2023-24, Payable on 1 December, 2023	Nov. 14	CI
NATCO Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 14	CI
US FDA Clears Natco Pharma's Pharmacovigilance Department in Hyderabad, India	Nov. 02	MT
Transcript : NATCO Pharma Limited - Shareholder/Analyst Call	23-09-29
Redcliffe Hygiene Private Limited announced that it has received INR 248 million in funding from Rainmatter, Alkemi Growth Capital LLP, NATCO Pharma Limited	23-09-11	CI
Indian Equities End Higher for Sixth Straight Day, Buoyed by Banking, Public Sector Enterprises	23-09-08	MT
Natco Pharma, Three Others Face Antitrust Violation Raps in US; Natco Pharma Shares Drop 3%	23-09-08	MT
Bristol Myers accused of illegal tactics to keep Pomalyst monopoly in lawsuit	23-09-06	RE
Indian shares set to open flat on caution ahead of GDP data	23-08-30	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News NATCO Pharma Limited

Equities

NATCOPHARM

INE987B01026

Summary

Filters